Robert Mark Richardson, MD, PhD
Not currently accepting new patients
Specialties
Affiliation
Mass General Brigham
Provider Locations
- Boston, MA
Dr. Richardson is the Charles Pappas Professor of Neurosciences in Neurosurgery at Harvard Medical School, Director of Functional Neurosurgery Innovation at MGB, and Visiting Professor of Brain and Cognitive Sciences at MIT.
Dr. Richardson completed the MD-PhD program at Virginia Commonwealth University's Medical College of Virginia and neurosurgical residency at the University of California, San Francisco. Dr. Richardson's clinical expertise includes awake brain mapping during tumor, epilepsy, and DBS surgery, robotic-assisted stereotactic surgery, and network surgery approaches to epilepsy, including Responsive Neurostimulation. He was Director of Epilepsy and Movement Disorders Surgery at the University of Pittsburgh Medical Center (UPMC) from 2011-2019, establishing one of the first comprehensive intraoperative MRI neurosurgery programs and an internationally recognized research program. There, he was the first surgeon to employ bilateral centromedian RNS to treat idiopathic generalized epilepsy. Dr. Richardson is an active advisor to several pioneering clinical trials of brain modulation, spanning closed-loop brain stimulation, gene therapy, and cell transplantation. He was the national surgical PI for the pivotal trial of SetPoint VNS for rheumatoid arthritis. He is a former member of the Executive Board of the American Society for Stereotactic and Functional Neurosurgery.
Dr. Richardson also is a neuroscientist who founded the Brain Modulation Lab, a human systems neuroscience lab with a mission to innovate surgical treatments for epilepsy, movement disorders, and psychiatric disease. Unique contributions of the Brain Modulation Lab include the first studies describing simultaneous cortical and subcortical recordings during speech, with support from the BRAIN Initiative, the first study describing biomarkers of therapeutic responsive neurostimulation for epilepsy, and the first study describing a biomarker of OCD symptomatology from sensing-enabled DBS recordings. Dr. Richardson co-founded the MGH-MIT InBRAIN Collaboration in 2020.
Education & Training
- Residency: UC San Francisco, Neurological Surgery, 2011
- Residency: University of California, General Surgery, 2006
- Medical Education: Virginia Commonwealth University School of Medicine, 2005
Board Certifications
- Neurological Surgery, American Board of Neurological Surgery
Languages Spoken
- English
Age Group Treated
- Adults
Patient Feedback
Accepted Insurance
- Tufts Medicare Preferred
- Wellpoint
- Senior Whole Health
- Medicaid ME
- Cigna
- Humana
- Maine Community Health Options
- MassHealth
- Tufts Health Plan
- Aetna
- Commonwealth Care Alliance
- United Health Care
- WellSense
- Medicaid NH
- Multiplan
- Medicaid RI
- Fallon Health
- Beech Street
- Medicaid CT
- Mass General Brigham Health Plan
- Medicaid VT
- Harvard Pilgrim Health Care
- Blue Cross Blue Shield Medicare
- WellSense NH
- Medicare
- TriCare
- Coventry
- Blue Cross Blue Shield